Wire flash
Bernstein cuts Boston Scientific price target to $60
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Bernstein, a research firm, has lowered its price target for Boston Scientific Corporation (a medical device company) from $72 to $60. The revision represents a bearish adjustment in the analyst's valuation of the company's stock. The source does not provide specific reasons for the downgrade, such as changes in market conditions, company performance, or product outlook. This forecast is attributed solely to Bernstein and reflects the firm's updated opinion on the stock's potential value.
Source
金十数据Neutral / independent
Part of this Story
Multiple Analysts Cut Boston Scientific Price Targets, Citi Downgrades to Neutral